TOWA PHARMACEUTICAL CO.,LTD. 4553Short Interest
No institution currently reports a short position of 0.5% or more in TOWA PHARMACEUTICAL CO.,LTD. (4553). The last disclosure was on 2026-11-11 (Barclays Capital Securities Ltd, 0.49%).
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
103 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It excludes 1 institutions whose last report is more than a year old (0.70% in total). It also excludes 6 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-11-14 |
|---|---|
| Latest disclosure | 2026-11-11 (Barclays Capital Securities Ltd, 0.49%) |
| Reporting institutions | 7 firms (103 reports) |
| Peak estimated short interest | 1.98% (2019-04-02, 3 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 4 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Barclays Capital Securities Ltd
- JPM Securities Japan Co Ltd.
- MERRILL LYNCH INTERNATIONAL
- Integrated Core Strategies (Asia) Pte. Ltd.
0.00%
Estimated short interest, 2026-11-18
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2018-07-23 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 121,400 shares | Ratio 0.70% | ▲0.09% | No report for 1+ year |
| 2022-02-10 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 257,536 shares | Ratio 0.49% | ▼0.01% | Below 0.5% |
| 2019-08-06 | Nomura International plc | Position 256,256 shares | Ratio 0.49% | ▼0.05% | Below 0.5% |
| 2026-11-11 | Barclays Capital Securities Ltd | Position 253,491 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2020-04-03 | Wellington Management Company LLP on behalf of Hawkes Bay Master Investors (Cayman) LP | Position 246,515 shares | Ratio 0.48% | ▼0.10% | Below 0.5% |
| 2026-01-20 | MERRILL LYNCH INTERNATIONAL | Position 245,913 shares | Ratio 0.47% | ▼0.18% | Below 0.5% |
| 2026-02-04 | JPM Securities Japan Co Ltd. | Position 237,155 shares | Ratio 0.46% | ▼0.13% | Below 0.5% |
Disclosure History 103 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-11 | Barclays Capital Securities Ltd | Position 253,491 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2026-11-06 | Barclays Capital Securities Ltd | Position 274,491 shares | Ratio 0.53% | ▲0.13% | — |
| 2026-10-29 | Barclays Capital Securities Ltd | Position 209,691 shares | Ratio 0.40% | ▼0.50% | Below 0.5% |
| 2026-10-27 | Barclays Capital Securities Ltd | Position 464,230 shares | Ratio 0.90% | ▲0.10% | — |
| 2026-10-19 | Barclays Capital Securities Ltd | Position 415,030 shares | Ratio 0.80% | ▲0.05% | — |
| 2026-10-15 | Barclays Capital Securities Ltd | Position 388,630 shares | Ratio 0.75% | ▼0.05% | — |
| 2026-10-14 | Barclays Capital Securities Ltd | Position 412,530 shares | Ratio 0.80% | ▲0.04% | — |
| 2026-10-02 | Barclays Capital Securities Ltd | Position 396,130 shares | Ratio 0.76% | ▼0.10% | — |
| 2026-09-15 | Barclays Capital Securities Ltd | Position 446,330 shares | Ratio 0.86% | ▼0.04% | — |
| 2026-09-02 | Barclays Capital Securities Ltd | Position 465,530 shares | Ratio 0.90% | ▲0.01% | — |
| 2026-08-19 | Barclays Capital Securities Ltd | Position 460,730 shares | Ratio 0.89% | ▼0.01% | — |
| 2026-08-17 | Barclays Capital Securities Ltd | Position 468,023 shares | Ratio 0.90% | ▲0.06% | — |
| 2026-08-07 | Barclays Capital Securities Ltd | Position 433,223 shares | Ratio 0.84% | ▼0.06% | — |
| 2026-07-30 | Barclays Capital Securities Ltd | Position 468,723 shares | Ratio 0.90% | ▲0.01% | — |
| 2026-07-29 | Barclays Capital Securities Ltd | Position 462,523 shares | Ratio 0.89% | ▼0.05% | — |
| 2026-07-22 | Barclays Capital Securities Ltd | Position 488,323 shares | Ratio 0.94% | ▼0.17% | — |
| 2026-07-15 | Barclays Capital Securities Ltd | Position 572,393 shares | Ratio 1.11% | ▲0.09% | — |
| 2026-07-08 | Barclays Capital Securities Ltd | Position 530,493 shares | Ratio 1.02% | ▲0.03% | — |
| 2026-07-07 | Barclays Capital Securities Ltd | Position 510,593 shares | Ratio 0.99% | ▲0.25% | — |
| 2026-07-03 | Barclays Capital Securities Ltd | Position 381,393 shares | Ratio 0.74% | ▲0.11% | — |
| 2026-06-30 | Barclays Capital Securities Ltd | Position 326,993 shares | Ratio 0.63% | ▲0.09% | — |
| 2026-06-26 | Barclays Capital Securities Ltd | Position 282,393 shares | Ratio 0.54% | ▲0.06% | — |
| 2026-06-23 | Barclays Capital Securities Ltd | Position 193,893 shares | Ratio 0.37% | ▼0.27% | Below 0.5% |
| 2026-06-22 | Barclays Capital Securities Ltd | Position 333,393 shares | Ratio 0.64% | ▲0.14% | — |
| 2026-06-18 | Barclays Capital Securities Ltd | Position 262,293 shares | Ratio 0.50% | ▲0.07% | — |
| 2026-05-14 | Barclays Capital Securities Ltd | Position 239,996 shares | Ratio 0.46% | ▼0.07% | Below 0.5% |
| 2026-05-12 | Barclays Capital Securities Ltd | Position 276,700 shares | Ratio 0.53% | ▼0.12% | — |
| 2026-04-30 | Barclays Capital Securities Ltd | Position 338,000 shares | Ratio 0.65% | ▲0.17% | — |
| 2026-04-24 | Barclays Capital Securities Ltd | Position 249,800 shares | Ratio 0.48% | ▼0.11% | Below 0.5% |
| 2026-04-20 | Barclays Capital Securities Ltd | Position 307,800 shares | Ratio 0.59% | ▼0.01% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| TSUMURA & CO.4540 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Mid400 |
| KISSEI PHARMACEUTICAL CO.,LTD.4547 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| SEIKAGAKU CORPORATION4548 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| EIKEN CHEMICAL CO.,LTD.4549 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| JCR Pharmaceuticals Co.,Ltd.4552 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| Fuji Pharma Co.,Ltd.4554 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 2 |
| CHUKYO IYAKUHIN CO.,LTD.4558 | Standard Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| ZERIA PHARMACEUTICAL CO.,LTD.4559 | Prime Market (Domestic) | Pharmaceutical | Pharmaceutical | TOPIX Small 1 |
| AnGes,Inc.4563 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| OncoTherapy Science,Inc.4564 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |